Filed before 2025Filed 22 October 2024
Mediar Therapeutics, Inc. has sold $85M so far
Mediar Therapeutics, Inc., a biotech company based in Boston, MA, has sold $85M so far in its equity round, according to a filing dated 22 October 2024.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 22 October 2024
- First filed
- 2 December 2022
- Round
- Equity round (amended filing)
- Amount sold
- $85M
- Offering size
- $85M
- Investors so far
- 17
- Based in
- Boston, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 95% of the 1,434 tracked raises with an amount filed in 2024, and than 83% of the 138 in biotech.
Mediar Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 23 Dec 2025 | New filing | $37.8M | Not tracked |
| 22 Oct 2024 | Amended filing | $85M | This raise |
| 9 Nov 2023 | Amended filing | $60.6M | This raise |
| 2 Dec 2022 | New filing | $31.8M | This raise |
| 6 Feb 2019 | New filing | $5M | Another raise |
More with Partners Innovation on the board
- Claris Biotherapeutics, Inc.$55.7M
- CodaMetrix Inc.$11.6M
- SeQure Dx Inc.$2.18M
- Abcuro, Inc.$120M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.